Details for New Drug Application (NDA): 050370
✉ Email this page to a colleague
NDA 050370 describes ILOTYCIN GLUCEPTATE, which is a drug marketed by Dista and is included in one NDA. Additional details are available on the ILOTYCIN GLUCEPTATE profile page.
The generic ingredient in ILOTYCIN GLUCEPTATE is erythromycin gluceptate. There are one hundred and three drug master file entries for this compound. Additional details are available on the erythromycin gluceptate profile page.
The generic ingredient in ILOTYCIN GLUCEPTATE is erythromycin gluceptate. There are one hundred and three drug master file entries for this compound. Additional details are available on the erythromycin gluceptate profile page.
Summary for 050370
| Tradename: | ILOTYCIN GLUCEPTATE |
| Applicant: | Dista |
| Ingredient: | erythromycin gluceptate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 250MG BASE/VIAL | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 500MG BASE/VIAL | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 1GM BASE/VIAL | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
